However, activated and functional CD8+ T cells can also overexpress PD-1 in cancer patients (Fourcade et al., 2010), and not all PD-1+ cells might respond equally to anti-PD-1 therapy (Thommen et al., 2018). This evidence concerns the gene PDCD1 and cancer.